CASC4 Products
(Cancer Susceptibility Candidate 4 (CASC4))
Categories
The increased expression level of this gene is associated with HER-2/neu proto-oncogene overexpression. Amplification and resulting overexpression of this proto-oncogene are found in approximately 30% of human breast and 20% of human ovarian cancers. Alternatively spliced variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Dec 2010].
antibodies-online.com stands for high-quality research products. Search, find and order tools with extensive validation data, images, references. Our scientific customer service is always at your disposal if you have any questions about the selection or application of our products.
Featured CASC4 Categories
CASC4 Antibodies
High quality antibodies with extensive validation data.
CASC4 Proteins
Proteins for various applications incl. WB, ELISA, IF etc.
Recommended CASC4 Antibodies
Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Human, Mouse
Application
WB, FACS, IHC (p), IHC
Validations
- (3)
Cat. No.
ABIN1977267
Quantity
200 μL
Datasheet
Datasheet
Reactivity
Human, Mouse
Application
WB, FACS
Validations
- (2)
Cat. No.
ABIN654468
Quantity
400 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB
Validations
- (1)
Cat. No.
ABIN6750740
Quantity
100 μL
Datasheet
Datasheet
Recommended CASC4 Proteins
Product
Reactivity
Source
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Human
Source
Wheat germ
Validations
- (1)
Cat. No.
ABIN1348083
Quantity
10 μg
Datasheet
Datasheet
Synonyms and alternative names related to CASC4
cancer susceptibility 4 (CASC4), cancer susceptibility candidate 4 (Casc4), cancer susceptibility candidate 4 (CASC4), cancer susceptibility 4 L homeolog (casc4.L), D130060C09Rik, H63, VGFG2573Protein level used designations for CASC4
- cancer susceptibility candidate gene 4 protein
- gene associated with HER-2/neu overexpression
- protein CASC4
- cancer susceptibility candidate gene 4 protein homolog
Did you look for something else?
You are here:
